Activate Immunotherapy
1997
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Later Stage VC
LATEST DEAL TYPE
3
INVESTORS
Description
Operator of a clinical-stage immuno-oncology company. The company utilizes a novel approach for activating the body's immune system to recognize and destroy cancer cells.
Website
Formerly Known As
NovaRx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Biotechnology
Primary Office
- 8395 Camino Santa Fe Drive
- Suite A
- San Diego, CA 92121
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Activate Immunotherapy’s full profile, request a free trial.
Activate Immunotherapy Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 15-Aug-2016 | 000.00 | Completed | Generating Revenue | ||
| 8. Merger/Acquisition | 02-May-2016 | Cancelled | Clinical Trials - Phase 3 | |||
| 7. Later Stage VC (Series C) | 01-Sep-2014 | 0000 | 000.00 | Completed | Generating Revenue | |
| 6. Later Stage VC (Series D) | 14-Mar-2007 | 0000 | 000.00 | Completed | Generating Revenue | |
| 5. Grant | 01-Jan-2007 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 4. Later Stage VC (Series B) | 26-Aug-2005 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 3. Grant | 12-May-2004 | 00.000 | Completed | Generating Revenue | ||
| 2. Grant | 01-Jan-2003 | $2.63M | Completed | Generating Revenue | ||
| 1. Grant | 09-Sep-2002 | $2.95M | Completed | Generating Revenue |
Activate Immunotherapy Investors (3)
Activate Immunotherapy Executive Team (12)
3 Former Executives
You’re viewing 5 of 12 executives. Get the full list »Activate Immunotherapy Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Justin Murdock | Activate Immunotherapy | Chief Executive Officer & Executive Chairman | 000 0000 |